Identification of polysaccharide capsules among extensively drug-resistant genitourinary Haemophilus parainfluenzae isolates.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 03 2019
Historique:
received: 05 10 2018
accepted: 21 02 2019
entrez: 16 3 2019
pubmed: 16 3 2019
medline: 2 10 2020
Statut: epublish

Résumé

The human commensal Haemophilus parainfluenzae is emerging as an opportunistic multidrug-resistant pathogen. The objectives of this work were to characterise a new capsular operon of extensively drug-resistant (XDR) H. parainfluenzae clinical isolates and study their resistance mechanisms using whole-genome sequencing. All strains were resistant to: ß-lactams, via amino acid changes in PBP3 (S385T, I442F, V511A, N526K and V562I); quinolones, by alterations in GyrA (S84F and D88Y) and ParC (S84F and S138T); chloramphenicol, through the presence of catS; macrolides, via the presence of mel and mef(E)-carrying MEGA element; and tetracycline, through the presence of tet(M) and/or tet(B). Phylogenetic analysis revealed high genomic diversity when compared to the H. parainfluenzae genomes available on the NCBI, the isolates from this study being closely related to the Swiss XDR AE-2096513. A full capsular operon showing homology to that of H. influenzae was identified, in accordance with the observation of a capsular structure by TEM. This study describes for the first time a capsular operon in H. parainfluenzae, a major determinant of pathogenicity that may contribute to increased virulence in XDR clinical isolates. Moreover, phylogenetic analysis suggests the possible spread of an XDR-encapsulated strain in Europe.

Identifiants

pubmed: 30872664
doi: 10.1038/s41598-019-40812-2
pii: 10.1038/s41598-019-40812-2
pmc: PMC6418240
doi:

Substances chimiques

Anti-Bacterial Agents 0
Macrolides 0
Polysaccharides, Bacterial 0
Quinolones 0
beta-Lactams 0
Chloramphenicol 66974FR9Q1
Tetracycline F8VB5M810T

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4481

Références

Antimicrob Agents Chemother. 2003 Mar;47(3):1017-22
pubmed: 12604536
Infect Immun. 2005 Aug;73(8):4653-67
pubmed: 16040978
Antimicrob Agents Chemother. 2009 Feb;53(2):343-53
pubmed: 19001115
Antimicrob Agents Chemother. 1996 Jul;40(7):1741-4
pubmed: 8807076
Can J Infect Dis Med Microbiol. 2010 Spring;21(1):e20-2
pubmed: 21358875
Antimicrob Agents Chemother. 2013 Jun;57(6):2867-9
pubmed: 23545526
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Pediatr Nephrol. 2007 Sep;22(9):1321-5
pubmed: 17541792
BMC Microbiol. 2008 Feb 25;8:35
pubmed: 18298818
J Med Microbiol. 2015 Jul;64(7):724-730
pubmed: 25976004
Can J Infect Dis Med Microbiol. 2016;2016:4503025
pubmed: 27516778
Clin Microbiol Infect. 2003 Jun;9(6):467-74
pubmed: 12848721
Clin Rheumatol. 2015 Apr;34(4):811-4
pubmed: 24584486
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
J Antimicrob Chemother. 2013 May;68(5):1054-9
pubmed: 23335113
Tex Heart Inst J. 2013;40(5):608-11
pubmed: 24391338
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Sex Transm Infect. 2016 Feb;92(1):29-31
pubmed: 26139207
Infect Genet Evol. 2016 Oct;44:507-509
pubmed: 27497656
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Microb Drug Resist. 2017 Sep;23(6):667-673
pubmed: 28103180
Genome Biol. 2014;15(11):524
pubmed: 25410596
J Antimicrob Chemother. 2008 Mar;61(3):509-14
pubmed: 18245789
J Antimicrob Chemother. 2011 Mar;66(3):673-5
pubmed: 21127039
Antimicrob Agents Chemother. 1996 Sep;40(9):2131-6
pubmed: 8878594
Infect Immun. 2003 Jun;71(6):3639-44
pubmed: 12761153
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
BMC Microbiol. 2016 Apr 06;16:62
pubmed: 27052615
J Microbiol Immunol Infect. 2015 Aug;48(4):450-2
pubmed: 23357607
Int J Antimicrob Agents. 2017 Feb;49(2):265-266
pubmed: 27986332
Clin Microbiol Rev. 2014 Apr;27(2):214-40
pubmed: 24696434
New Microbiol. 2009 Apr;32(2):213-5
pubmed: 19579703

Auteurs

Aida González-Díaz (A)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain.

Fe Tubau (F)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain.

Miguel Pinto (M)

Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.

Yanik Sierra (Y)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.

Meritxell Cubero (M)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain.

Jordi Càmara (J)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain.

Josefina Ayats (J)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain.

Paula Bajanca-Lavado (P)

Haemophilus influenzae Reference Laboratory, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.

Carmen Ardanuy (C)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain. c.ardanuy@bellvitgehospital.cat.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain. c.ardanuy@bellvitgehospital.cat.

Sara Marti (S)

Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain. smartinm@bellvitgehospital.cat.
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain. smartinm@bellvitgehospital.cat.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH